Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pediatric Lianhua Qinggan Granules for Acute Upper Respiratory Infection (Wind-Heat Cold)
CTR20212969Phase 2Completed
- Sponsor
- Yiling Pharmaceutical
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Xiaoer Lianhua Qinggan in upper respiratory infection (URI), sponsored by Yiling Pharmaceutical. Started Nov 2021; status: completed.
02
Drugs
Xiaoer Lianhua Qinggan
03
Conditions
upper respiratory infection (URI)
Beyond the preview
Go deeper on CTR20212969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212969.